NCT07081750

Brief Summary

This interventional study aims to evaluate the efficacy of a dyadic tailored home-based activity program in managing behavioral and psychological symptoms of dementia (BPSD) among home-dwelling people living with mild-to-moderate dementia post-discharge. The main question it aims to answer is: Does the dyadic tailored home-based activity program significantly reduce BPSD in individuals with mild-to-moderate dementia after hospital discharge? Researchers will compare people living with mild to moderate dementia who are receiving routine care to see if the dyadic tailored home-based activity program is effective for BPSD. Participants will:

  1. 1.During hospitalization: People living with mild to moderate dementia and their caregivers receive health education on managing behavioral and psychological symptoms of dementia (BPSD); Participating activity sessions to assess individual preferences and functional activity capabilities, followed by co-designing a dyadic tailored home-based activity program.
  2. 2.After discharge: People living with mild to moderate dementia and their caregivers jointly receive a 12-week dyadic tailored home-based activity intervention at home.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jul 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jul 2025Jun 2026

First Submitted

Initial submission to the registry

July 6, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

July 20, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

12 months

First QC Date

July 6, 2025

Last Update Submit

July 16, 2025

Conditions

Keywords

dementiabehavioral and psychological symptomshome-basedactivity

Outcome Measures

Primary Outcomes (2)

  • Behavioral and Psychological Symptoms of Dementia

    Assessment using the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 144, with higher scores indicating more severe neuropsychiatric symptoms

    Baseline and post-intervention (at the end of week 12)

  • Caregiver Distress of Behavioral and Psychological Symptoms of Dementia

    Assessment using the caregiver distress section of the Neuropsychiatric Inventory (NPI) yields scores ranging from 0 to 60, with higher scores indicating greater caregiver distress levels

    Baseline and post-intervention (at the end of week 12)

Secondary Outcomes (16)

  • Cognitive Function of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Activities of Daily Living of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Apathy of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Agitation of Dementia Patients

    Baseline and post-intervention (at the end of week 12)

  • Quality of Life in Dementia

    Baseline and post-intervention (at the end of week 12)

  • +11 more secondary outcomes

Other Outcomes (3)

  • Number of caregivers with varying levels of satisfaction towards the intervention

    Post-intervention (at the end of week 12)

  • Number of dementia patients with varying levels of satisfaction towards the intervention

    Post-intervention (at the end of week 12)

  • Number of completed activity intervention sessions for dementia patients

    Post-intervention (at the end of week 12)

Study Arms (2)

Dyadic tailored home-based activity program intervention

EXPERIMENTAL

(1) During hospitalization, caregivers receive health education on managing behavioral and psychological symptoms of dementia. Patient-caregiver dyads participate in structured ward activities to assess activity preferences and capabilities, forming the basis for co-developing individualized home activity plans with training for caregivers. (2) A customized home activity kit is provided at discharge. (3) Post-discharge, a 12-week tailored home intervention is implemented, using a patient-centered model with caregiver support. Caregivers record participation and behavioral responses, which inform dynamic adjustments to activity content, difficulty, and methods.

Behavioral: Dyadic tailored home-based activity program intervention

Routine care

ACTIVE COMPARATOR

Participants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.

Other: Routine care

Interventions

1. During hospitalization, caregivers receive health education on managing behavioral and psychological symptoms of dementia. Patient-caregiver dyads participate in structured ward activities to assess activity preferences and capabilities, forming the basis for co-developing individualized home activity plans with training for caregivers. 2. A customized home activity kit is provided at discharge. 3. Post-discharge, a 12-week tailored home intervention is implemented, using a patient-centered model with caregiver support. Caregivers record participation and behavioral responses, which inform dynamic adjustments to activity content, difficulty, and methods.

Dyadic tailored home-based activity program intervention

Participants will receive routine care consisting of standard hospitalization treatment, basic caregiver education on behavioral and psychological symptoms of dementia (BPSD), routine discharge instructions (including general home activity recommendations without personalized intervention assessment, planning or implementation), and routine post-discharge follow-up for 12 weeks.

Routine care

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients:
  • Aged ≥60 years;
  • ICD-10 diagnosed dementia with Clinician's Dementia Rating (CDR) scores of 1-2 (mild-to-moderate stage);
  • Preserved basic verbal communication capacity;
  • Exhibit at least one neuropsychiatric symptom (score ≥1 on any item) in the past month, as assessed by the Neuropsychiatric Inventory (NPI);
  • Medically cleared for discharge with planned home-based care;
  • Willing to provide written informed consent.
  • Caregivers:
  • Aged ≥18 years;
  • Designated primary caregiver (the individual spends the longest time caring for the patient each day);
  • Committed to maintaining home caregiving responsibilities for at least 3 months post-discharge;
  • Intact verbal communication skills;
  • Possess basic operational proficiency with the WeChat application (capable of independently sending/receiving messages and conducting voice/video calls)
  • Willing to provide written informed consent.

You may not qualify if:

  • Patients:
  • Comorbid severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or psychiatric disorders;
  • Severe visual or hearing impairment;
  • Dementia caused by the following conditions: Central nervous system diseases (e.g., encephalitis, brain tumors, epilepsy, multiple sclerosis, Parkinson's disease); Nutritional/metabolic disorders (e.g., thyroid dysfunction, vitamin B12/folate deficiency); Substance or alcohol dependence; Other potential etiologies of secondary dementia;
  • Severe physical or mental illness, extreme debilitation, long-term bedridden status, end-stage disease (with a life expectancy of less than six months), or an inability to cooperate with or tolerate the study;
  • Currently participating in other medical research that may interfere with study outcomes.
  • Caregivers:
  • Comorbid severe somatic diseases (e.g., malignant tumors, heart failure, physical disabilities) or psychiatric disorders;
  • Severe visual or hearing impairment;
  • Currently participating in other medical research that may interfere with study outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

DementiaBehaviorMotor Activity

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Researcher

Study Record Dates

First Submitted

July 6, 2025

First Posted

July 23, 2025

Study Start

July 20, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

July 23, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share